Healthcare Stocks

Omega Diagnostics (ODX) shares slump over 30%: Should you hold?

 Omega Diagnostics (ODX) shares slump over 30%: Should you hold?

Highlights  Omega Diagnostics Group reported a statutory loss of £2.75 million for the H1 2021, as its contract with the UK Department of Health and Social Care (DHSC) ended. Omega Diagnostics’ revenue from its Global Heal...

Read More...
Covid-19: Van-Tan Assures Usage of Astrazeneca Vaccine Safe for Brits

Covid-19: Van-Tan Assures Usage of Astrazeneca Vaccine Safe for Brits

Summary At a press conference at the Downing Street on Monday, Professor Jonathan Van-Tan reassured Brits that they were safe after South Africa suspended AstraZeneca’s vaccine rollout. A recent study has highlighted that AstraZeneca-Oxfo...

Read More...
Active Biotech and Famar Health Care sign a manufacturing deal 

Active Biotech and Famar Health Care sign a manufacturing deal 

Summary Both the healthcare sector companies have signed a contract on Thursday, 4 February. Under the agreement, Famar Health will be providing Active Biotech with clinical trial material.  &nb...

Read More...
Astrazeneca’s Covid-19 Vaccine Efficient for Elders, Says UK Regulators

Astrazeneca’s Covid-19 Vaccine Efficient for Elders, Says UK Regulators

Summary The British-Swedish pharma major has come up with extra trial data which shows that vaccine is effective in the elderly group Some of the European nations have been doubting whether the vaccine is effective on elderly age group or not ...

Read More...
Sensyne Health Unveils AI Algorithm for Real-Time Hospital Management 

Sensyne Health Unveils AI Algorithm for Real-Time Hospital Management 

Summary Sensyne Health unveiled its first operational artificial intelligence algorithm SYNE-OPS-1 The SYNE-OPS-1 provides real-time operational decision-making support to healthcare managers.  The company's CEO Lord Drayson plans to...

Read More...
Jazz Pharmaceuticals acquires GW Pharmaceuticals for £5.3 billion

Jazz Pharmaceuticals acquires GW Pharmaceuticals for £5.3 billion

Summary GW Pharmaceuticals has announced that Ireland’s Jazz Pharmaceuticals will be buying it out for £3 billion in a cash and stock deal.  The deal is likely to close by the second quarter of this year. GW’s drug ...

Read More...
McKinsey agrees to $573mn multi-state opioid settlement 

McKinsey agrees to $573mn multi-state opioid settlement 

Summary McKinsey has agreed to a multi-state settlement claim of at least US $573 million for its sales and marketing advice to Oxycontin maker Purdue Pharma. McKinsey’s settlement claims are with 43 states, the District of Columbia and t...

Read More...
AstraZeneca Oxford vaccine could lead to fall in coronavirus spread, claims study

AstraZeneca Oxford vaccine could lead to fall in coronavirus spread, claims study

Summary A scientific study suggests that a single dose of the AstraZeneca Oxford vaccine lowers the Covid-19 virus transmission by two-third. A single shot offers 76 per cent immunity against the virus for up to a period of three months. A...

Read More...
Moderna Inc (NASDAQ: MRNA) initiates additional filling of vials containing Covid-19 vaccine 

Moderna Inc (NASDAQ: MRNA) initiates additional filling of vials containing Covid-19 vaccine 

Summary The pharma company has proposed increasing of filling vials by up to five additional doses. The US FDA had initially purchased 200 million doses of Moderna vaccine, following which it ordered additional 100 million jabs. ...

Read More...
Valneva shares jump 16% after UK government decides to procure 40 mn more vaccine doses

Valneva shares jump 16% after UK government decides to procure 40 mn more vaccine doses

Summary Shares of Valneva jumped 16 per cent after the UK government procured 40 million additional doses of its Covid-19 vaccine. After the jump, the shares of Valneva SE hit a fresh all-time high on the&nbsp...

Read More...
UK May Get Its Fourth Covid-19 Vaccine, Novavax Shows High Efficacy in Phase III Trials

UK May Get Its Fourth Covid-19 Vaccine, Novavax Shows High Efficacy in Phase III Trials

Summary                  The new Novavax vaccine has an 86 per cent efficacy against the coronavirus. Novavax will be produced in association with Teesside University in England. The UK has sought 60 ...

Read More...